Vycor Medical (VYCO) Long-Term Deferred Tax (2014 - 2025)

Vycor Medical (VYCO) has reported Long-Term Deferred Tax for 9 consecutive years, with $19.9 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Long-Term Deferred Tax changed 0.1% year-over-year to $19.9 million in Q4 2025; TTM through Dec 2025 was $19.9 million, a 0.1% change from a year earlier, with the FY2025 full-year figure at $19.9 million, changed 0.1% from the prior year.
• Long-Term Deferred Tax was $19.9 million for Q4 2025 at Vycor Medical, roughly flat from $19.9 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $19.9 million in Q4 2024 and troughed at $19.1 million in Q4 2021.
• A 5-year average of $19.7 million and a median of $19.9 million in 2022 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax rose 4.32% in 2022 and declined 0.1% in 2025, its largest moves.
• Over 5 years, Long-Term Deferred Tax stood at $19.1 million in 2021, then climbed by 4.32% to $19.9 million in 2022, then increased by 0.04% to $19.9 million in 2023, then grew by 0.06% to $19.9 million in 2024, then fell by 0.1% to $19.9 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $19.9 million (Q4 2025), $19.9 million (Q4 2024), and $19.9 million (Q4 2023), per Business Quant data.